You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
豐原藥業(000153.SZ):擬參投合肥康弘生物醫藥大健康產業投資中心
格隆匯 12-22 18:20

格隆匯12月22日丨豐原藥業(000153.SZ)公佈,為推動安徽豐原藥業股份有限公司高質量發展、充分利用專業投資機構在投資併購領域的廣泛佈局及資源整合能力,促進公司未來發展,加快生物醫藥及大健康產業的佈局,2023年12月21日,公司召開第九屆董事會第十五次會議,審議通過了《關於與專業投資機構共同投資產業基金的議案》,同意公司與北京京工弘元投資管理有限公司、上海樸弘投資有限公司及北京九城投資有限公司共同投資設立合肥康弘生物醫藥大健康產業投資中心(有限合夥)(名稱最終以工商註冊為準,簡稱“合夥企業”或“產業基金”或“基金”)。合夥企業認繳出資總額2億元人民幣,其中,公司作為有限合夥人以自有資金認繳出資1.5億元人民幣。投資範圍為生物醫藥及大健康相關領域的創業期和成長期股權投資標的。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account